verified SJR 1,436 · Q1 • database Scopus / SJR & Web of Science indexed

Germany · Georg Thieme Verlag

workspace_premium Q1 — Hematology lock Subscription

Thrombosis and Haemostasis

Thrombosis and Haemostasis is a journal indexed in SJR in Hematology with an H index of 211. It has an SJR impact factor of 1,436 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,436.

Thrombosis and Haemostasis focuses its scope in these topics and keywords: human, factor, atrial, clinical, protein, expression, plasminogen, inhibition, patients, neonatal, ...

ISSN: 0340-6245

Publisher: Georg Thieme Verlag

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,436 Q1

H-index 211

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,436

H-index

211

Docs (year)

132

Docs 3y

618

Total refs

4996

Cites 3y

2270

Citable 3y

516

Cites/Doc 2y

3.55

Ref/Doc

37.85

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antithrombotic role of nitric oxide in rats under physiological conditions

What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life?

Decreased anticoagulant response to tissue factor pathway inhibitor in patients with venous thromboembolism and otherwise no evidence of hereditary or acquired thrombophilia

Crosstalk between coagulation and inflammation during Dengue virus infection

Critical residues for ligand binding in blade 2 of the propeller domain of the integrin aIIb subunit

Contribution of PAR-1, PAR-4 and GPIba in intracellular signaling leading to the cleavage of the beta3 cytoplasmic domain during thrombin-induced platelet aggregation

Coagulopathy of sepsis

Clot penetration and fibrin binding of amediplase, a chimeric plasminogen activator (K2tu-PA)

Cloning of the cDNA Encoding Human Platelet CD36: Comparison to PCR Amplified Fragments of Monocyte, Endothelial and HEL Cells

Circulating platelet-derived microparticles in systemic lupus erythematosus

Circulating levels of inflammatory cytokines (IL-1beta and TNF-a), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies

Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin

SHOW MORE ARTICLES

Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities

A 6-month Venographic Follow-up in 164 Patients with Acute Deep Vein Thrombosis

Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism

Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation

Age- and sex-specific incidence, risk, and latency period of a perioperative acute thromboembolism syndrome (PATS)

Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina

Activation-dependent surface expression of gC1qR/p33 on human blood platelets

Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection

Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium

Aberrant mucosal wound repair in the absence of secretory leukocyte protease inhibitor

A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: Is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples?

A Novel Platelet Activating Factor Antagonist, SM-12502, Attenuates Endotoxin-induced Disseminated Intravascular Coagulation and Acute Pulmonary Vascular Injury by Inhibiting TNF Production in Rats

FAQs

Thrombosis and Haemostasis has an SJR of 1,436 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Thrombosis and Haemostasis is 20%.

Thrombosis and Haemostasis

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Thrombosis and Haemostasis?

What is the APC / publication cost?

What is the acceptance rate?